467 related articles for article (PubMed ID: 17657601)
1. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
Zhang HY; Yan H; Tang XC
Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
[TBL] [Abstract][Full Text] [Related]
2. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.
Zhang HY; Tang XC
Trends Pharmacol Sci; 2006 Dec; 27(12):619-25. PubMed ID: 17056129
[TBL] [Abstract][Full Text] [Related]
4. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A.
Yang L; Ye CY; Huang XT; Tang XC; Zhang HY
J Alzheimers Dis; 2012; 31(1):131-42. PubMed ID: 22531425
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
Wang R; Tang XC
Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
[TBL] [Abstract][Full Text] [Related]
6. New insights into huperzine A for the treatment of Alzheimer's disease.
Zhang HY
Acta Pharmacol Sin; 2012 Sep; 33(9):1170-5. PubMed ID: 22941287
[TBL] [Abstract][Full Text] [Related]
7. Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease.
Damar U; Gersner R; Johnstone JT; Schachter S; Rotenberg A
Med Hypotheses; 2017 Feb; 99():57-62. PubMed ID: 28110700
[TBL] [Abstract][Full Text] [Related]
8. An update on huperzine A as a treatment for Alzheimer's disease.
Little JT; Walsh S; Aisen PS
Expert Opin Investig Drugs; 2008 Feb; 17(2):209-15. PubMed ID: 18230054
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
Zhang HY; Zheng CY; Yan H; Wang ZF; Tang LL; Gao X; Tang XC
Chem Biol Interact; 2008 Sep; 175(1-3):396-402. PubMed ID: 18565502
[TBL] [Abstract][Full Text] [Related]
10. Role of huperzine a in the treatment of Alzheimer's disease.
Desilets AR; Gickas JJ; Dunican KC
Ann Pharmacother; 2009 Mar; 43(3):514-8. PubMed ID: 19240260
[TBL] [Abstract][Full Text] [Related]
11. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.
Ha GT; Wong RK; Zhang Y
Chem Biodivers; 2011 Jul; 8(7):1189-204. PubMed ID: 21766442
[TBL] [Abstract][Full Text] [Related]
12. [Huperzine a: an acetylcholinesterase inhibitor with high pharmacological potential].
Pilotaz F; Masson P
Ann Pharm Fr; 1999 Sep; 57(5):363-73. PubMed ID: 10520506
[TBL] [Abstract][Full Text] [Related]
13. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.
Friedli MJ; Inestrosa NC
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940
[TBL] [Abstract][Full Text] [Related]
14. Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation.
Xiao XQ; Zhang HY; Tang XC
J Neurosci Res; 2002 Jan; 67(1):30-6. PubMed ID: 11754078
[TBL] [Abstract][Full Text] [Related]
15. Huperzine A--an interesting anticholinesterase compound from the Chinese herbal medicine.
Patocka J
Acta Medica (Hradec Kralove); 1998; 41(4):155-7. PubMed ID: 9951045
[TBL] [Abstract][Full Text] [Related]
16. Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.
Wang CY; Zheng W; Wang T; Xie JW; Wang SL; Zhao BL; Teng WP; Wang ZY
Neuropsychopharmacology; 2011 Apr; 36(5):1073-89. PubMed ID: 21289607
[TBL] [Abstract][Full Text] [Related]
17. East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A.
Li WM; Kan KK; Carlier PR; Pang YP; Han YF
Curr Alzheimer Res; 2007 Sep; 4(4):386-96. PubMed ID: 17908041
[TBL] [Abstract][Full Text] [Related]
18. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
Wang R; Yan H; Tang XC
Acta Pharmacol Sin; 2006 Jan; 27(1):1-26. PubMed ID: 16364207
[TBL] [Abstract][Full Text] [Related]
19. Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Camps P; Muñoz-Torrero D
Mini Rev Med Chem; 2001 Jul; 1(2):163-74. PubMed ID: 12369981
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Badia A; Baños JE; Camps P; Contreras J; Görbig DM; Muñoz-Torrero D; Simón M; Vivas NM
Bioorg Med Chem; 1998 Apr; 6(4):427-40. PubMed ID: 9597187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
